SANDOZ AFATINIB
Identification of Sandoz Afatinib
No description |
Google image searchProduct monograph
Active ingredient
afatinib (afatinib dimaleate), 20 MG
DIN: 02512777
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: SANDOZ CANADA INCORPORATED
Date: 28-OCT-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EB — Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (ATC, ATC/DDD)
- L01EB03 — AFATINIB (ATC/DDD)
Reference brand drug: Giotrif
External Links for Sandoz Afatinib
Search on Google
Sandoz Canada Incorporated
Go to Sandoz website to see drug product details. Sometimes you can find sandoz afatinib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.